Why I bought 850 shares of $BNGO

He invested about £6,000 of inherited money in 850 BNGO shares, targeting genomics alongside electric vehicles and plant-based foods. His thesis is that BNGO’s genomic technology could help treat disease, while low valuation and S-curve position offer 2x–10x potential. He expects Cathie Wood’s ARK inclusion to drive gains, may reach 1,000 shares, and intends to hold long-term.

Speculative upside is prioritized over technical research, continuing his concentrated-investing shift.